James E Allison

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease
    James E Allison
    Division of Research, Kaiser Permanente Medical Care Program, Northern California Region, 2000 Broadway, Oakland, CA 94612, USA
    Arch Intern Med 163:1165-71. 2003
  2. ncbi FIT: a valuable but underutilized screening test for colorectal cancer-it's time for a change
    James E Allison
    Division of Research, Kaiser Permanente, Northern California, Oakland, California, USA
    Am J Gastroenterol 105:2026-8. 2010
  3. ncbi Screening tests for colorectal cancer: a menu of options remains relevant
    James E Allison
    University of California San Francisco, San Francisco General Hospital Campus, NH 3D, San Francisco, CA 94110, USA
    Curr Oncol Rep 8:492-8. 2006
  4. ncbi New screening guidelines for colorectal cancer: a practical guide for the primary care physician
    James E Allison
    Division of Gastroenterology, San Francisco General Hospital, 1001 Potrero Avenue, NH 3D, San Francisco, CA 94110, USA
    Prim Care 36:575-602. 2009
  5. ncbi Natural history of severe ulcerative colitis in a community-based health plan
    James Allison
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Clin Gastroenterol Hepatol 6:999-1003. 2008
  6. ncbi Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system
    Fernando S Velayos
    Division of Gastroenterology, Department of Internal Medicine, University of California, San Francisco 94115, USA
    Gastroenterology 139:1511-8. 2010
  7. ncbi Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Gastroenterology 137:502-11. 2009
  8. ncbi Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010
    Lisa J Herrinton
    Kaiser Permanente Northern California, Oakland, CA, USA
    Gastroenterology 143:382-9. 2012
  9. ncbi Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics
    James E Allison
    Division of Research, Kaiser Permanente Northern California Region, 2000 Broadway, Oakland, CA 94612 2304, USA
    J Natl Cancer Inst 99:1462-70. 2007
  10. ncbi Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, 94612, USA
    Am J Gastroenterol 106:2146-53. 2011

Detail Information

Publications18

  1. ncbi A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease
    James E Allison
    Division of Research, Kaiser Permanente Medical Care Program, Northern California Region, 2000 Broadway, Oakland, CA 94612, USA
    Arch Intern Med 163:1165-71. 2003
    ....
  2. ncbi FIT: a valuable but underutilized screening test for colorectal cancer-it's time for a change
    James E Allison
    Division of Research, Kaiser Permanente, Northern California, Oakland, California, USA
    Am J Gastroenterol 105:2026-8. 2010
    ....
  3. ncbi Screening tests for colorectal cancer: a menu of options remains relevant
    James E Allison
    University of California San Francisco, San Francisco General Hospital Campus, NH 3D, San Francisco, CA 94110, USA
    Curr Oncol Rep 8:492-8. 2006
    ..In this review we discuss the rationale for caution in designating one screening test as "the best" and present information on how new stool and serum tests can be used effectively to screen for CRC...
  4. ncbi New screening guidelines for colorectal cancer: a practical guide for the primary care physician
    James E Allison
    Division of Gastroenterology, San Francisco General Hospital, 1001 Potrero Avenue, NH 3D, San Francisco, CA 94110, USA
    Prim Care 36:575-602. 2009
    ..Armed with this information, primary care physicians will be better educated as to the importance of offering screening to their patients, as well as the strength and weaknesses of each recommended test...
  5. ncbi Natural history of severe ulcerative colitis in a community-based health plan
    James Allison
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Clin Gastroenterol Hepatol 6:999-1003. 2008
    ..We sought to evaluate long-term outcomes of patients with severe ulcerative colitis (UC) after their first hospitalization for the disease...
  6. ncbi Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system
    Fernando S Velayos
    Division of Gastroenterology, Department of Internal Medicine, University of California, San Francisco 94115, USA
    Gastroenterology 139:1511-8. 2010
    ..Limited data are available on rates of colonoscopy surveillance and factors associated with surveillance...
  7. ncbi Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Gastroenterology 137:502-11. 2009
    ..The management of inflammatory bowel disease (IBD) has become increasingly complicated, and it is unknown whether poor outcomes (prolonged steroid use, hospitalizations, and surgery) have declined in the general population...
  8. ncbi Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010
    Lisa J Herrinton
    Kaiser Permanente Northern California, Oakland, CA, USA
    Gastroenterology 143:382-9. 2012
    ..The relationship between inflammatory bowel disease (IBD) and the incidence and mortality of colorectal adenocarcinoma (CRC) has not been evaluated recently...
  9. ncbi Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics
    James E Allison
    Division of Research, Kaiser Permanente Northern California Region, 2000 Broadway, Oakland, CA 94612 2304, USA
    J Natl Cancer Inst 99:1462-70. 2007
    ..Thus, improving the sensitivity of FOBT should make colon cancer screening programs that use these tests more effective...
  10. ncbi Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, 94612, USA
    Am J Gastroenterol 106:2146-53. 2011
    ..The objective of this study was to assess inflammatory bowel disease (IBD) medications in relation to lymphoma risk...
  11. ncbi Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006
    Oren Abramson
    Division of Pediatric Gastroenterology, Kaiser Permanente Northern California, Santa Clara, CA 95051, USA
    J Pediatr 157:233-239.e1. 2010
    ..To examine the incidence and prevalence of pediatric inflammatory bowel disease (IBD) during 1996-2006 in a community-based health-care delivery system...
  12. ncbi Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization
    Liyan Liu
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Pharmacoepidemiol Drug Saf 18:1086-93. 2009
    ..Resources for studying inflammatory bowel disease (IBD) are needed in evaluations of drug safety including traditional drugs and new biologics agents. We developed an IBD registry, with ascertainment from computerized visit information...
  13. ncbi Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease
    Andrea Altschuler
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Inflamm Bowel Dis 14:992-9. 2008
    ....
  14. ncbi Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization
    Xiaoping Weng
    Division of Research, Kaiser Permanente, Oakland, California 94612, USA
    Am J Gastroenterol 102:1429-35. 2007
    ....
  15. ncbi Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Inflamm Bowel Dis 13:451-61. 2007
    ..There are few contemporary estimates of prevalence rates for inflammatory bowel disease (IBD) in diverse North American communities...
  16. ncbi Stool DNA and occult blood testing for screen detection of colorectal neoplasia
    David A Ahlquist
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Ann Intern Med 149:441-50, W81. 2008
    ..Stool DNA testing is a new approach to colorectal cancer detection. Few data are available from the screening setting...
  17. ncbi Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT
    James E Allison
    Gastroenterology 129:745-8. 2005
  18. ncbi Immunochemical fecal occult blood tests for colorectal cancer screening
    James E Allison
    Am J Med 116:498; author reply 498-9. 2004